JEGI CLARITY Has Advised Hypothesis On Their Sale To Elixirr


(MENAFN- PR Newswire) NEW YORK, Oct. 21, 2024 /PRNewswire/ -- Hypothesis, advised by
JEGI CLARITY, has been sold to Elixirr.

Hypothesis is an insights and strategy firm founded in 2000. They help companies better understand their customers by providing insights, competitor intelligence and strategic advice to inform the design of products and services. Their offerings include quantitative research, qualitative research, advanced analytics, strategic brand and consulting services, and design. Hypothesis' "mixed methodology" approach integrates qualitative and quantitative capabilities in a single engagement to combine human insights with large-scale data analysis – an approach that is viewed as a key differentiator by clients.

The acquisition brings specialist expertise in qualitative research, quantitative research and strategic insights, complementing Elixirr's existing service offerings and enhancing their ability to support clients from initial research and discovery through to strategy definition and delivery. In addition to an expansion of capabilities, Hypothesis has deep expertise in additive industries for Elixirr, particularly as a result of its significant presence in the technology, media and entertainment, and retail and CPG industries. Hypothesis' strong US presence and outstanding reputation will add immediate scale and help to accelerate Elixirr's growth in the US.

About JEGI CLARITY
JEGI CLARITY is a pre-eminent M&A advisory firm for the media, events, marketing, information and technology industries. With a global reach from New York, London, Boston, and Sydney, we have closed more than 800 transactions during our 35+ year history. For more information, visit

Contact:
Kelsey Kovachik
Vice President of Marketing
+1 212 754 0710
[email protected]

SOURCE JEGI CLARITY

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN21102024003732001241ID1108803803


PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.